Inhibition of SRC corrects GM-CSF hypersensitivity that underlies juvenile myelomonocytic leukemia.
about
Juvenile myelomonocytic leukemia: molecular pathogenesis informs current approaches to therapy and hematopoietic cell transplantationCbl-mediated K63-linked ubiquitination of JAK2 enhances JAK2 phosphorylation and signal transduction.SOCS-1 mediates ubiquitylation and degradation of GM-CSF receptor.Dasatinib targets B-lineage cells but does not provide an effective therapy for myeloproliferative disease in c-Cbl RING finger mutant mice.UBASH3B/Sts-1-CBL axis regulates myeloid proliferation in human preleukemia induced by AML1-ETO.An International MDS/MPN Working Group's perspective and recommendations on molecular pathogenesis, diagnosis and clinical characterization of myelodysplastic/myeloproliferative neoplasms.Clinical management of myelodysplastic syndrome/myeloproliferative neoplasm overlap syndromes.Src family kinases and their role in hematological malignancies.Turning the tide in myelodysplastic/myeloproliferative neoplasms.Structural Determinants of the Gain-of-Function Phenotype of Human Leukemia-associated Mutant CBL Oncogene.Juvenile myelomonocytic leukaemia-associated mutation in Cbl promotes resistance to apoptosis via the Lyn-PI3K/AKT pathway.Novel approaches to diagnosis and treatment of Juvenile Myelomonocytic Leukemia.Role of Non Receptor Tyrosine Kinases in Hematological Malignances and its Targeting by Natural Products.ABL tyrosine kinase inhibitor-induced pulmonary alveolar proteinosis in chronic myeloid leukemia.
P2860
Q26851000-C01DE0FA-2D85-4DD3-8D1C-F6023BD19AAFQ33870784-F86F02E4-565F-4C1F-AD67-AEEA21861014Q35006328-97A4F146-7540-4B6C-8C39-B102D9530D20Q35144330-D1354508-4DAB-456D-8E89-F797E5EF2ABDQ36642902-B6B69DE8-3D3F-4817-9A17-E5A7E50AAD21Q36708989-3D6A31FD-D399-4DCE-8337-620B0DDCAFD7Q37349392-863E33CB-3593-43C8-A0C1-A8CA57B682DFQ38217719-F9E86680-54C6-41C1-9DFA-AF00B9957684Q38712988-DF5A00B6-56B9-489E-A57E-8B7327BC8272Q38721532-D982D1F0-7461-497F-8A29-EF3FB9F5D62FQ39029990-1E2F1D49-B6E8-4978-A674-F04E2ABA93C9Q48557504-4F9818CB-E3C4-4475-9F52-8CEA4CE1E432Q49887894-958A73E0-0CD3-412B-AD23-3406D72BF7A2Q51698195-7ED913E7-AA9B-4D84-B845-E5E5457B54B1
P2860
Inhibition of SRC corrects GM-CSF hypersensitivity that underlies juvenile myelomonocytic leukemia.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
2013年论文
@zh
2013年论文
@zh-cn
name
Inhibition of SRC corrects GM- ...... enile myelomonocytic leukemia.
@en
Inhibition of SRC corrects GM- ...... enile myelomonocytic leukemia.
@nl
type
label
Inhibition of SRC corrects GM- ...... enile myelomonocytic leukemia.
@en
Inhibition of SRC corrects GM- ...... enile myelomonocytic leukemia.
@nl
prefLabel
Inhibition of SRC corrects GM- ...... enile myelomonocytic leukemia.
@en
Inhibition of SRC corrects GM- ...... enile myelomonocytic leukemia.
@nl
P2093
P1433
P1476
Inhibition of SRC corrects GM- ...... enile myelomonocytic leukemia.
@en
P2093
Danielle H Shin
Helene Favre
Julie Weng
Meredith S Irwin
Michael Ohh
Michelle W Kang
Mignon L Loh
Severa Bunda
Stephanie S Sybingco
P304
P356
10.1158/0008-5472.CAN-12-3425
P407
P577
2013-02-11T00:00:00Z